Final Efficacy Results From Impower132: First-Line Atezolizumab Plus Chemotherapy In Patients With Stage Iv Non-Squamous NsclcM. Nishio,F. Barlesi,S. Ball,R. Bordoni,M. Cobo, P. Dubray-Longeras,J. Goldschmidt,S. Novello, F. J. Orlandi,R. Sanborn,Z. Szalai, G. Ursol,D. Mendus,L. Wang,X. Wen, M. Mccleland,T. Hoang,S. Phan,M. SocinskiAnnals of Oncology(2020)引用 8|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要